medRxiv PreprintsInternational13 October 2026
MRI Biomarkers for Brain Metastases in Lung Cancer Using Machine Learning
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Purpose: Existing prognostic models for brain metastases from lung cancer rely on clinical variables and do not capture the biological heterogeneity of host or tumor factors underlying survival outcomes. We evaluated whether MRI-derived radiomic biomarkers improve prognostic stratification beyond clinical variables. We also investigated their biological correlates using matched histopathology. Experimental Design: This retrospective study included 103 patients with brain metastases from lung cancer and matched pre-operative MRI and histopathology. Radiomic features from T1-weighted contrast-en
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Language eligibility criteria and enrolled racial and ethnic composition in US clinical trials: a cross-sectional study13 October 2026
- Contrasting Patterns of Cortical Volume Change in First-Episode Schizophrenia-Spectrum Psychosis13 October 2026
- Atrial fibrillation begets atrial fibrillation - serum-driven amplification of atrial electrical instability13 October 2026
- Vascular Remodelling in Idiopathic Nephrotic Syndrome with Administration of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers13 October 2026
- Association of childhood experiences with wellbeing and flourishing outcomes in Indian adults: Evidence from the India Sample of the Global Flourishing Study (GFS)13 October 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.